Effects of Horizontal vs Vertical Switching of Disease-Modifying Treatment After Platform Therapies on Disease Activity in Patients With Relapsing–Remitting MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria
J Neurol 2023 Mar 02;[EPub Ahead of Print], M Guger, C Enzinger, F Leutmezer, F Di Pauli, J Kraus, S Kalcher, E Kvas, T BergerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.